Validation of the Colorado retinopathy of prematurity screening model

Medicine & Life Sciences

• Retinopathy of Prematurity 100%
• Birth Weight 9%
• Gestational Age 9%
• Body-Weight Trajectory 5%
• Growth 5%
• Cohort Studies 4%
• Gestational Weight Gain 4%
• North American Indians 4%
• Validation Studies 3%
• Premature Infants 3%
• African Americans 3%
• Weight Gain 3%
• Canada 3%
• Multicenter Studies 3%
• Datasets 2%
• Data Analysis 2%
• Sensitivity and Specificity 2%
• Retrospective Studies 2%
• Mothers 2%
• Population 1%
• Therapeutics 1%